Daily FNArena News

Global nuclear capacity is steadily increasing, while uranium production will soon fall short of demand. But when?

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Brokers debate whether the “reflation trade” is on, thus suggesting a switch out of defensive stocks and into cyclicals.

A glance through the latest expert views and predictions about commodities with updated expectations for commodity markets, bullish views on gold and oil and commentary on bulks and aluminium.

This week ATW’s Jerry Simmons examines US equities and sees scope for a not unusual solar-based movement. Energy, softs, currencies and US bonds are also considered.

You are hereby invited to express your personal view on the share market. The survey takes up a few minutes only – and it closes midnight today!

Bionomics has moved into the cancer stem cell field through a US acquisition and on the news Bell Potter reiterates its Buy rating for the stock.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Morgan Stanley sees the potential for the ASX to downgrade its FY13 earnings outlook at its AGM.

Weekly update on recommendation, target price, and earnings forecast changes.

Silex Systems is developing laser-based uranium enrichment technology and the company has received good news with a licence for a proposed plant being recommended by US regulators.

This week’s Tweets on Twitter by Your Editor.